# Erie Indemnity Co: financial statements, quarterly

ERIE · Nasdaq · CIK 922621 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/erie.md) · [Financials](/companies/erie/financials.md) · [Filings](/companies/erie/filings.md) · [Insiders](/companies/erie/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/erie/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [818 d](/filings/0001628280-26-010666.md) | [881](/filings/0000922621-25-000016.md) | [990](/filings/0001628280-25-038926.md) | [1,000](/filings/0001628280-25-047555.md) | [924 d](/filings/0001628280-26-010666.md) | [989](/filings/0001628280-26-026866.md) | [1,060](/filings/0001628280-26-051079.md) | [1,067](/filings/0001628280-26-068274.md) | [951 d](/filings/0001628280-26-010666.md) | [1,012](/filings/0001628280-26-026866.md) | [1,090](/filings/0001628280-26-051079.md) | [1,070](/filings/0001628280-26-068274.md) |
| Operating income | $m | [127 d](/filings/0001628280-26-010666.md) | [139](/filings/0000922621-25-000016.md) | [190](/filings/0001628280-25-038926.md) | [180](/filings/0001628280-25-047555.md) | [167 d](/filings/0001628280-26-010666.md) | [151](/filings/0001628280-26-026866.md) | [199](/filings/0001628280-26-051079.md) | [209](/filings/0001628280-26-068274.md) | [158 d](/filings/0001628280-26-010666.md) | [167](/filings/0001628280-26-026866.md) | [204](/filings/0001628280-26-051079.md) | [207](/filings/0001628280-26-068274.md) |
| Interest expense | $m | [0.0 d](/filings/0000922621-24-000006.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [29.0 d](/filings/0001628280-26-010666.md) | [32.8](/filings/0000922621-25-000016.md) | [43.4](/filings/0001628280-25-038926.md) | [41.0](/filings/0001628280-25-047555.md) | [39.8 d](/filings/0001628280-26-010666.md) | [36.3](/filings/0001628280-26-026866.md) | [46.1](/filings/0001628280-26-051079.md) | [49.9](/filings/0001628280-26-068274.md) | [19.0 d](/filings/0001628280-26-010666.md) | [39.9](/filings/0001628280-26-026866.md) | [47.8](/filings/0001628280-26-051079.md) | [50.8](/filings/0001628280-26-068274.md) |
| Net income | $m | [111 d](/filings/0001628280-26-010666.md) | [125](/filings/0001628280-25-047555.md) | [164](/filings/0001628280-25-047555.md) | [160](/filings/0001628280-25-047555.md) | [152 d](/filings/0001628280-26-010666.md) | [138](/filings/0001628280-26-068274.md) | [175](/filings/0001628280-26-068274.md) | [183](/filings/0001628280-26-068274.md) | [63.4 d](/filings/0001628280-26-010666.md) | [150](/filings/0001628280-26-068274.md) | [180](/filings/0001628280-26-068274.md) | [182](/filings/0001628280-26-068274.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [930](/filings/0000922621-25-000004.md) | [942](/filings/0000922621-24-000010.md) | [1,020](/filings/0000922621-24-000019.md) | [1,097](/filings/0000922621-24-000023.md) | [1,145](/filings/0001628280-26-010666.md) | [1,122](/filings/0000922621-25-000016.md) | [1,269](/filings/0001628280-25-038926.md) | [1,498](/filings/0001628280-25-047555.md) | [1,199](/filings/0001628280-26-068274.md) | [1,161](/filings/0001628280-26-026866.md) | [1,207](/filings/0001628280-26-051079.md) | [1,313](/filings/0001628280-26-068274.md) |
| Total assets | $m | [2,472](/filings/0000922621-25-000004.md) | [2,556](/filings/0000922621-24-000010.md) | [2,692](/filings/0000922621-24-000019.md) | [2,864](/filings/0000922621-24-000023.md) | [2,889](/filings/0001628280-26-010666.md) | [2,968](/filings/0000922621-25-000016.md) | [3,128](/filings/0001628280-25-038926.md) | [3,324](/filings/0001628280-25-047555.md) | [3,355](/filings/0001628280-26-068274.md) | [3,377](/filings/0001628280-26-026866.md) | [3,557](/filings/0001628280-26-051079.md) | [3,662](/filings/0001628280-26-068274.md) |
| Current liabilities | $m | [709](/filings/0000922621-25-000004.md) | [728](/filings/0000922621-24-000010.md) | [772](/filings/0000922621-24-000019.md) | [807](/filings/0000922621-24-000023.md) | [803](/filings/0001628280-26-010666.md) | [812](/filings/0000922621-25-000016.md) | [862](/filings/0001628280-25-038926.md) | [898](/filings/0001628280-25-047555.md) | [946](/filings/0001628280-26-068274.md) | [900](/filings/0001628280-26-026866.md) | [968](/filings/0001628280-26-051079.md) | [1,005](/filings/0001628280-26-068274.md) |
| Total liabilities | $m | [809](/filings/0000922621-25-000004.md) | [830](/filings/0000922621-24-000010.md) | [863](/filings/0000922621-24-000019.md) | [916](/filings/0000922621-24-000023.md) | [901](/filings/0001628280-26-010666.md) | [901](/filings/0000922621-25-000016.md) | [944](/filings/0001628280-25-038926.md) | [1,015](/filings/0001628280-25-047555.md) | [1,072](/filings/0001628280-26-068274.md) | [1,023](/filings/0001628280-26-026866.md) | [1,090](/filings/0001628280-26-051079.md) | [1,110](/filings/0001628280-26-068274.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,663](/filings/0001628280-26-010666.md) | [1,726](/filings/0001628280-25-047555.md) | [1,829](/filings/0001628280-25-047555.md) | [1,948](/filings/0001628280-25-047555.md) | [1,987](/filings/0001628280-26-068274.md) | [2,067](/filings/0001628280-26-068274.md) | [2,185](/filings/0001628280-26-068274.md) | [2,309](/filings/0001628280-26-068274.md) | [2,283](/filings/0001628280-26-068274.md) | [2,354](/filings/0001628280-26-068274.md) | [2,467](/filings/0001628280-26-068274.md) | [2,553](/filings/0001628280-26-068274.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [148 d](/filings/0001628280-26-010666.md) | [87.2](/filings/0000922621-25-000016.md) | [131 d](/filings/0001628280-25-038926.md) | [199 d](/filings/0001628280-25-047555.md) | [193 d](/filings/0001628280-26-010666.md) | [118](/filings/0001628280-26-026866.md) | [178 d](/filings/0001628280-26-051079.md) | [219 d](/filings/0001628280-26-068274.md) | [172 d](/filings/0001628280-26-010666.md) | [91.9](/filings/0001628280-26-026866.md) | [215 d](/filings/0001628280-26-051079.md) | [213 d](/filings/0001628280-26-068274.md) |
| Capital expenditure | $m | [20.5 d](/filings/0001628280-26-010666.md) | [22.4](/filings/0000922621-25-000016.md) | [28.0 d](/filings/0001628280-25-038926.md) | [27.7 d](/filings/0001628280-25-047555.md) | [46.6 d](/filings/0001628280-26-010666.md) | [29.7](/filings/0001628280-26-026866.md) | [20.3 d](/filings/0001628280-26-051079.md) | [35.0 d](/filings/0001628280-26-068274.md) | [30.8 d](/filings/0001628280-26-010666.md) | [37.4](/filings/0001628280-26-026866.md) | [41.5 d](/filings/0001628280-26-051079.md) | [28.0 d](/filings/0001628280-26-068274.md) |
| Dividends paid | $m | [55.4 d](/filings/0001628280-26-010666.md) | [59.4](/filings/0000922621-25-000016.md) | [59.4 d](/filings/0001628280-25-038926.md) | [59.4 d](/filings/0001628280-25-047555.md) | [59.4 d](/filings/0001628280-26-010666.md) | [63.6](/filings/0001628280-26-026866.md) | [63.6 d](/filings/0001628280-26-051079.md) | [63.6 d](/filings/0001628280-26-068274.md) | [63.6 d](/filings/0001628280-26-010666.md) | [68.1](/filings/0001628280-26-026866.md) | [68.1 d](/filings/0001628280-26-051079.md) | [68.1 d](/filings/0001628280-26-068274.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:29 ET. No prices; not investment advice.